Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of Pathology ; (12): 318-320, 2014.
Article in Chinese | WPRIM | ID: wpr-292301

ABSTRACT

<p><b>OBJECTIVE</b>To detect the expression of pan-neuronal marker protein gene product (PGP)9.5 and its clinicopathologic significance in breast cancer.</p><p><b>METHODS</b>The expression of PGP9.5 was examined by immunohistochemistry EnVision method in 196 cases during 2007 to 2011, including 20 normal tissues, 14 cases of fibroadenoma, 18 cases of ductal carcinoma in situ (DCIS) and 144 cases of invasive ductal carcinoma (IDC) of the breast. The relationship between PGP9.5 expression and clinicopathologic characteristics of IDC was assessed.</p><p><b>RESULTS</b>PGP9.5 expression was localized in the stroma of all normal breast tissues, but there was no expression observed in all fibroadenomas and DCIS. Overall, the expression rate of PGP9.5 in IDC was 61.8% (89/144). PGP9.5 expression increased from grade 1 tumors (29.4%, 10/34) to grade 2-3 tumors (71.8%, 79/110; P = 0.000). In addition, patients with less than 3 years disease-free survival tended to show higher PGP9.5 expression (64.8%, 35/54), compared to patients with equal to and/or more than 3 years disease-free survival (46.7%, 42/90; P = 0.035). However, there was no correlation between PGP9.5 expression and tumor size, tumor stage, lymph metastasis, hormone receptor expression.</p><p><b>CONCLUSION</b>PGP9.5 expression is correlated with tumor grade and prognosis in IDC of the breast.</p>


Subject(s)
Adult , Aged , Female , Humans , Middle Aged , Biomarkers, Tumor , Metabolism , Breast Neoplasms , Metabolism , Pathology , Carcinoma, Ductal, Breast , Metabolism , Pathology , Carcinoma, Intraductal, Noninfiltrating , Metabolism , Pathology , Disease-Free Survival , Fibroadenoma , Metabolism , Pathology , Neoplasm Grading , Ubiquitin Thiolesterase , Metabolism
2.
Chinese Journal of Pathology ; (12): 827-830, 2014.
Article in Chinese | WPRIM | ID: wpr-304381

ABSTRACT

<p><b>OBJECTIVE</b>To investigate whether cannabinoid receptor 1 (CB1R) is involved in nerve growth in endometriosis-associated ectopic cyst.</p><p><b>METHODS</b>The effect of CB1R agonist and antagonist on the expression of pan-neuronal marker protein gene product (PGP) 9.5 in ectopic cyst was examined by immunofluorescence and Western blot in endometriosis model of 18 rats.</p><p><b>RESULTS</b>Immunofluorescence revealed that PGP 9.5 was expressed in the nerve fibers and was mainly distributed in the cyst hilum. Western blot revealed that the protein density of either PGP 9.5 (2 week: 0.38 ± 0.05; 4 week: 0.63 ± 0.03; 8 week: 0.80 ± 0.07, P < 0.01) or CB1R (2 week: 0.48 ± 0.04; 4 week: 0.68 ± 0.01; 8 week: 0.80 ± 0.03, P < 0.01) in the ectopic cyst increased with cyst size. In addition, compared to control group (0.75 ± 0.01), PGP 9.5 expression in the ectopic cyst was promoted by CB1R agonist ACPA (0.81 ± 0.01, P < 0.05), and inhibited by CB1R antagonist AM251 (0.67 ± 0.03, P < 0.01).</p><p><b>CONCLUSIONS</b>CB1R was involved in the nerve growth of ectopic cyst associated with endometriosis.</p>


Subject(s)
Animals , Female , Rats , Blotting, Western , Cysts , Metabolism , Disease Models, Animal , Endometriosis , Metabolism , Peripheral Nerves , Metabolism , Piperidines , Pharmacology , Pyrazoles , Pharmacology , Receptor, Cannabinoid, CB1 , Physiology , Ubiquitin Thiolesterase , Metabolism
SELECTION OF CITATIONS
SEARCH DETAIL